These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8188400)
1. Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention. Beccari M Int J Artif Organs; 1994 Jan; 17(1):5-13. PubMed ID: 8188400 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin associated hypertension among pediatric dialysis patients. Komatsu Y; Ito K Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845 [TBL] [Abstract][Full Text] [Related]
4. Effects of erythropoietin on blood pressure. Raine AE; Roger SD Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):76-83. PubMed ID: 1928084 [TBL] [Abstract][Full Text] [Related]
5. Pediatric uses of recombinant human erythropoietin: the outlook in 1991. Alexander SR Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis. Yamakado M; Umezu M; Nagano M; Tagawa H Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212 [TBL] [Abstract][Full Text] [Related]
8. Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose. Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):343-54. PubMed ID: 26889660 [TBL] [Abstract][Full Text] [Related]
9. Seizures in haemodialysis patients treated with recombinant human erythropoietin. Edmunds ME; Walls J; Tucker B; Baker LR; Tomson CR; Ward M; Cunningham J; Moore R; Winearls CG Nephrol Dial Transplant; 1989; 4(12):1065-9. PubMed ID: 2517327 [TBL] [Abstract][Full Text] [Related]
10. The impact of recombinant human erythropoietin therapy on renal transplantation. Ettenger RB; Marik J; Grimm P Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):57-61. PubMed ID: 1928081 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia]. Ohkubo M; Ishimitsu T; Kawaguchi T; Abe M; Yagi S Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):171-7. PubMed ID: 8315880 [TBL] [Abstract][Full Text] [Related]
12. [Correction of anemia in chronic kidney failure with lyophilized recombinant human erythropoietin using a subcutaneous approach]. Amar M; Cendoroglo Neto M; Canziani ME; Nadaletto MA; Ajzen H; Draibe SA Rev Assoc Med Bras (1992); 1994; 40(2):101-7. PubMed ID: 7820145 [TBL] [Abstract][Full Text] [Related]
14. Impact of erythropoietin on the dialysis prescription. Van Wyck DB Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial. Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974 [TBL] [Abstract][Full Text] [Related]
16. The adverse effects of recombinant human erythropoietin therapy. Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088 [No Abstract] [Full Text] [Related]
17. [Treatment of anemia in chronically dialyzed patients]. Moynot A Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055 [No Abstract] [Full Text] [Related]
18. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human erythropoietin (rHuEPO) on nutritional status of hemodialysis patients: investigation of direct anabolic effects of rHuEPO. Usuba T; Kuno T; Higuchi T; Kikuchi F; Nagura Y; Kanmatsuse K; Takahashi S Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1288-95. PubMed ID: 7853762 [TBL] [Abstract][Full Text] [Related]
20. Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients? de Fijter CW; Popp-Snijders C; Oe LP; Tran DD; van der Meulen J; Donker AJ Haematologica; 1995; 80(4):332-4. PubMed ID: 7590502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]